ZECUITY Drug Patent Profile

✉ Email this page to a colleague

When do Zecuity patents expire, and what generic alternatives are available?

Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine patents protecting this drug.

This drug has ninety-two patent family members in fourteen countries.

The generic ingredient in ZECUITY is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zecuity

A generic version of ZECUITY was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6^th, 2009.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ZECUITY?
What are the global sales for ZECUITY?
What is Average Wholesale Price for ZECUITY?

Summary for ZECUITY

International Patents:	92
US Patents:	9
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	70
Clinical Trials:	1
Patent Applications:	4,191
DailyMed Link:	ZECUITY at DailyMed

Drug patent expirations by year for ZECUITY

Recent Clinical Trials for ZECUITY

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NuPathe Inc.	Phase 1

See all ZECUITY clinical trials

US Patents and Regulatory Information for ZECUITY

ZECUITY is protected by nine US patents.

Patents protecting ZECUITY

Transdermal methods and systems for the delivery of anti-migraine compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Pharmacokinetics of iontophoretic sumatriptan administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Polyamine enhanced formulations for triptan compound iontophoresis
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A FLOWABLE HYDROGEL FORMULATION

Pharmacokinetics of iontophoretic sumatriptan administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Electronic control of drug delivery system
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Transdermal methods and systems for the delivery of anti-migraine compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

User-activated self-contained co-packaged iontophoretic drug delivery system
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZECUITY

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ZECUITY

See the table below for patents covering ZECUITY around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	2643048	SYSTÈME DE DISTRIBUTION DE MÉDICAMENTS IONTOPHORÉTIQUE CO-EMBALLÉ AUTONOME ACTIVÉ PAR L'UTILISATEUR (USER-ACTIVATED SELF-CONTAINED CO-PACKAGED IONTOPHORETIC DRUG DELIVERY SYSTEM)	⤷ Sign Up
Israel	209755	הרכבי פוליאמין מוגברים עבור יונתופוריזה של תרכובת טריפטאן (Polyamine enhanced formulations for triptan compound iontophoresis)	⤷ Sign Up
Eurasian Patent Organization	201100891	ЭЛЕКТРОННЫЙ КОНТРОЛЬ СИСТЕМЫ ДОСТАВКИ ЛЕКАРСТВЕННОГО СРЕДСТВА	⤷ Sign Up
South Korea	20050103941	IONTOPHORETIC DRUG DELIVERY SYSTEM	⤷ Sign Up
Australia	2007238685	Transdermal methods and systems for the delivery of anti-migraine compounds	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ZECUITY

Recent Clinical Trials for ZECUITY

Patents protecting ZECUITY

Make Better Decisions: Try a trial or see plans & pricing